Serum Fuc-Hpt levels increased with liver disease progression from normal volunteers, to chronic hepatitis patients, to liver cirrhosis patients, and could be a potential predictive biomarker for hepatocellular carcinoma [10]. This evidence concerns the gene MRS2 and hepatocellular carcinoma.